Sitemap

Use of this website is subject to the "Terms of Use" which are found on the link above.

Please email any questions to us at:

info at shimoda-atlantic.com

Cancer News Updates from Oncolink

Cisplatin superior to carboplatin for treating curable lung cancer

Daily folic acid supplement does not reduce colorectal adenoma risk

Tissue-selective estrogen complex inhibits bone loss without breast, uterine effects

High calcium intake linked to increased prostate cancer risk

Less aggressive approach to neuroblastoma still effective

External beam radiotherapy no benefit in early endometrial cancer


Shark cartilage extract of no benefit in non-small cell lung cancer


Clinical Trials . . .

We are currently prescreening potential patients for a solid tumor study. This study will utilize a cationic magnetite liposome labeled magnetite nanoparticle as part of a novel therapy targeting solid tumors,





For information, email:

Clinical Trials

or call us at 479.636.0500 ext. 222

Featured link of the week . . .

Please read our privacy policy and the terms of use of our website. All contents of our website are the copyright property © 1978-2005, ShimodaAtlantic™ - all rights reserved under US and international law. ShimodaAtlantic™ and Xenavex™ are trademarks of ShimodaAtlantic Oncology BioSciences LLC. No item found on this website, incluiding links, should be construed as intended to diagnose of treat any disease.